Bioactivity and molecular docking studies of new diarylnonanoids and constituents from the fruits of Myristica cagayanensis with anti-inflammatory activity in human neutrophils
Year: 2026
Type: article
Abstract: Myristica cagayanensis is a tropical aromatic plant and recognized as a source of diverse secondary metabolites. In the present study, five new diarylnonanoid derivatives, including myriscagayanones A ( 1 ), myriscagayanones B ( 2 ), myriscagayanones C ( 3 ), myriscagayanones D ( 4 ), and myriscagayanones E ( 5 ), together with fifteen known compounds ( 6 – 20 ), were isolated and identified from the fruits of M. cagayanensis . Their inhibitory effects on O 2 •– generation in fMLP/CB-stimulated human neutrophils were evaluated. Among the tested compounds, myriscagayanone C ( 3 ) (IC 50 = 5.12 ± 0.76 μM) and demethyldactyloidin ( 16 ) (IC 50 = 4.06 ± 0.28 μM) exhibited the most potent inhibitions. SAR analysis suggested that hydroxyl substitution patterns within the diarylnonanoid skeleton may contribute to the observed inhibitory activity. Molecular docking targeting FPR1 suggested possible binding poses and residue-interaction patterns for the active compounds. In addition, in silico predictions provided preliminary physicochemical descriptors for compounds and indicated that several active compounds may warrant further investigation. These findings expand the phytochemical knowledge of M. cagayanensis and highlight the fruits of this species as a source of structurally diverse constituents capable of inhibiting neutrophil superoxide generation, supporting further investigation of their potential anti-inflammatory properties.
Source: Industrial Crops and Products
Authors: Sin-Ling Wang, Sin-Min Li, Jih-Jung Chen
Language: English
Topic: Bioactive natural compounds
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,720
OpenAlex ID: W7237356133
